Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ALEC
#3420
Alector, Inc. Common Stock
2.5
8
USD
+7.05%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+7.05%
Changement Mensuel
+15.70%
Evolution sur 6 mois
-19.88%
Changement Annuel
+145.71%
Clôture Précédente
2.4
1
Open
2.5
8
Bid
Ask
Low
2.5
8
High
2.5
8
Volume
37
Marchés
Actions des Marchés US
Soins de Santé
ALEC
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
99.09 M
99.99 M
101.21 M
109.15 M
110.36 M
—
Valuation ratios
Enterprise value
163.64 M
94.48 M
106.46 M
256.2 M
116.05 M
573.19 M
Price to earnings ratio
-1.54
-0.98
-1.21
-2.77
-1.12
-6.07
Price to sales ratio
1.81
1.35
1.68
4.17
7.63
14.83
Price to cash flow ratio
-0.79
-0.52
-0.64
-1.49
-0.87
-3.53
Price to book ratio
1.44
0.24
0.33
0.84
5.24
6.66
Enterprise value to EBITDA ratio
-1.23
-0.74
-0.89
-2.1
-0.88
-4.6
Profitability ratios
Return on assets %
-0
-0.1
-0.09
-0.1
-0.13
-0.42
Return on equity %
-0.02
-0.43
-0.43
-0.6
-1.22
-2.67
Return on invested capital %
-20.07
-132.81
-115.26
-152.77
-190.31
-591.16
Gross margin %
100
100
100
100
100
400
Operating margin %
-13.36
-1 207.97
-433.55
-1 153.62
-637.03
-3 432.18
EBITDA margin %
-18.04
-1 260.19
-454.98
-1 198.8
-656.26
-3 570.23
Net margin %
-3.82
-1 093.81
-387.66
-1 063.4
-600.02
-3 144.89
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.4
3.34
3.78
3.76
3.83
14.71
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.11
0.01
0.02
0.01
0.02
0.06
Solvency ratios
Debt to assets ratio
0.02
0.02
0.03
0.03
0.03
0.11
Debt to equity ratio
0.07
0.1
0.13
0.17
0.32
0.72
Long term debt to total assets ratio
0.02
0.02
0.03
0.03
0.03
0.11
Long term debt to total equity ratio
0.07
0.1
0.13
0.17
0.3
0.7
Per share metrics
Operating cash flow per share
-0.57
-0.61
-0.49
-0.32
-0.4
-1.82
EBIT per share
-0.07
-0.45
-0.34
-0.37
-0.38
-1.54
EBITDA per share
-0.1
-0.47
-0.36
-0.38
-0.4
-1.6
Total debt per share
0.1
0.1
0.1
0.09
0.09
0.38
Cash per share
4.28
3.57
3.06
2.84
2.49
11.95
Net current asset value per share
4.4
3.69
3.18
2.93
2.59
12.38
Tangible book value per share
1.31
0.95
0.71
0.56
0.3
2.52
Working capital per share
3.1
2.58
2.34
2.15
1.91
8.98
Book value per share
1.31
0.95
0.71
0.56
0.3
2.52
Nouvelles
Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key (NASDAQ:ALEC)
Alector (ALEC)'s Technical Outlook is Bright After Key Golden Cross
BTIG relève Alector à l’achat sur fond de technologie BBB-shuttle
Alector stock rating upgraded to Buy at BTIG on BBB-shuttle focus
Alector à la conférence TD Cowen : faire progresser les thérapies cérébrales
Alector at TD Cowen Conference: Advancing Brain Therapeutics
Le BPA de Alector a dépassé les attentes de 0,05$, le CA a surpassé les prévisions
Alector earnings beat by $0.05, revenue topped estimates
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates
VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates
Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst (ALEC)
Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript